Mirski D

References (4)

Title : Switching From Donepezil to Rivastigmine Is Well Tolerated: Results of an Open-Label Safety and Tolerability Study - Sadowsky_2005_Prim.Care.Companion.J.Clin.Psychiatry_7_43
Author(s) : Sadowsky CH , Farlow MR , Atkinson L , Steadman J , Koumaras B , Chen M , Mirski D
Ref : Prim Care Companion J Clin Psychiatry , 7 :43 , 2005
Abstract : Sadowsky_2005_Prim.Care.Companion.J.Clin.Psychiatry_7_43
ESTHER : Sadowsky_2005_Prim.Care.Companion.J.Clin.Psychiatry_7_43
PubMedSearch : Sadowsky_2005_Prim.Care.Companion.J.Clin.Psychiatry_7_43
PubMedID: 15841194

Title : Risk of antipsychotic drug use in patients with Alzheimer's disease treated with rivastigmine - Suh_2004_Drugs.Aging_21_395
Author(s) : Suh DC , Arcona S , Thomas SK , Powers C , Rabinowicz AL , Shin H , Mirski D
Ref : Drugs & Aging , 21 :395 , 2004
Abstract : Suh_2004_Drugs.Aging_21_395
ESTHER : Suh_2004_Drugs.Aging_21_395
PubMedSearch : Suh_2004_Drugs.Aging_21_395
PubMedID: 15084141

Title : Impact of rivastigmine use on the risk of nursing home placement in a US sample - Beusterien_2004_CNS.Drugs_18_1143
Author(s) : Beusterien KM , Thomas SK , Gause D , Kimel M , Arcona S , Mirski D
Ref : CNS Drugs , 18 :1143 , 2004
Abstract : Beusterien_2004_CNS.Drugs_18_1143
ESTHER : Beusterien_2004_CNS.Drugs_18_1143
PubMedSearch : Beusterien_2004_CNS.Drugs_18_1143
PubMedID: 15581384

Title : Analysis of outcome in retrieved dropout patients in a rivastigmine vs placebo, 26-week, Alzheimer disease trial - Farlow_2003_Arch.Neurol_60_843
Author(s) : Farlow M , Potkin S , Koumaras B , Veach J , Mirski D
Ref : Archives of Neurology , 60 :843 , 2003
Abstract : Farlow_2003_Arch.Neurol_60_843
ESTHER : Farlow_2003_Arch.Neurol_60_843
PubMedSearch : Farlow_2003_Arch.Neurol_60_843
PubMedID: 12810489